Leslie Holsinger

Executive Vice President, IRulya Therapeutics Inc.

Companies

IRulya Therapeutics Inc.Executive Vice President May 8, 2019 to Jun 8, 2022¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

IRulya Therapeutics Inc. QNCX148,080 shares²$4.9M at $33.23Jun 6, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

Jun 6, 2022Shares withheld for tax 10,920 shares at $2.86 of IRulya Therapeutics Inc.²
Mar 3, 2022Granted 155,500 shares of IRulya Therapeutics Inc.³

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARIRulya Therapeutics Inc., Executive Vice President
2
SEC EDGARIRulya Therapeutics Inc. shares after the filing of Jun 6, 2022
3
SEC EDGARForm 4 filed Mar 4, 2022